All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

[M]{.smallcaps}ethicillin-resistant *Staphylococcus aureus* (MRSA) *spa*-type t127, Sequence Type (ST) 1, was first reported as one of the three most prevalent MRSA lineages in Italian pig industry, present in 6% of the holdings surveyed in Italy in 2008 \[[@pone.0137143.ref001]\]. ST1 belongs to Clonal Complex (CC)1, a particularly successful lineage associated with human infections, which includes Panton-Valentine (PVL)-positive CA-MRSA also known as USA400 \[[@pone.0137143.ref002]\]. In Europe, PVL-positive ST1 CA-MRSA *SCCmec* V, was firstly reported in a Dutch patient (2005--2006) \[[@pone.0137143.ref003]\], then in an Italian patient (2007) after travel in the USA \[[@pone.0137143.ref004]\], and in Denmark \[[@pone.0137143.ref005]\]. In the United Kingdom, PVL-negative ST1, *spa*-type t127, *SCCmec* IVa isolates are among the most common CA-MRSA, often associated with injecting drug-users and homeless people \[[@pone.0137143.ref006]\]. Furthermore, ST1 *spa*-type t127 isolates have been reported as the sixth most prevalent clone, both MSSA and MRSA, isolated from human invasive infections in Europe \[[@pone.0137143.ref007],[@pone.0137143.ref008]\].

As previously reported \[[@pone.0137143.ref009]\] *spa*-type t127 ST1 isolates of porcine origin shared a 75% similarity when tested by pulse field gel electrophoresis (PFGE) with isolates of human origin. They showed mainly differences in the *SCCmec* cassette and in some virulence and antimicrobial resistance marker genes.

In Italy, in the last five years, the CC1 lineage has also been increasingly detected in dairy cattle mastitis (Battisti, unpublished) \[[@pone.0137143.ref010], [@pone.0137143.ref011]\], in bulk milk from dairy cattle, and occasionally from goat milk and colonizing veal calves and small ruminants \[[@pone.0137143.ref012]\]. The aim of the study was to analyse the differences between isolates from food-producing animals and humans isolated in Italy and other European countries and to determine their genetic relatedness for epidemiological and risk assessment purposes.

Materials and Methods {#sec002}
=====================

A total of 83 ST(CC)1 *S*. *aureus* (71 MRSA and 12 MSSA) were studied ([Fig 1](#pone.0137143.g001){ref-type="fig"}). The majority (n = 65) were from Italy (including 30 MRSA from pigs, 18 MRSA from bovines, 8 MRSA from humans; 1 MSSA from bovine, 1 MSSA from pig, 1 MSSA from ovine, and 6 MSSA from human) and the remainders from Finland (6 MRSA from pigs), Spain (4 MRSA and one MSSA from pigs and 2 MSSA from humans), Denmark (4 MRSA from humans), Cyprus (1 MRSA from pigs).

![Dendrogram of SmaI PFGE macrorestriction patterns, with selected virulence and antimicrobial resistance marker genes and elements of Sequence Type 1, Clonal Complex 1 MSSA and MRSA from animals and humans.\
Legend: ^†^ LukF-PV(P83)-LukM; ^‡^ vwb (COL+MW2); ^☼^Ciprofloxacin resistance; ^§^ PFGE profile. Notes: \**SCCmec*V&*SCCfus*; \*\* *SCCmec* IV (2B&5), subtype IVa.](pone.0137143.g001){#pone.0137143.g001}

Isolates from animals (n = 63, 2007--2011) were collected from population-based studies in different primary productions (surveys in pigs, cattle), and passive laboratory surveillance programmes (mastitis in dairy cattle and sheep). The Italian isolates originated from farms located in Northern and Central Italy. For the purpose of the study, only one representative isolate per *spa*-type and ST per epidemiological unit (i. e. per holding) was included. The 20 isolates of human origin (8 MSSA and 12 MRSA, 1999--2011) investigated in this study were derived from previous laboratory surveillances \[[@pone.0137143.ref005],[@pone.0137143.ref008],[@pone.0137143.ref009],[@pone.0137143.ref013]\], originated from infections, and were of unknown epidemiological relationships with animal farming \[[@pone.0137143.ref009]\]. Metadata of the isolates under study are included in [S1 Table](#pone.0137143.s001){ref-type="supplementary-material"}.

Most of isolates of animal origin (e. g. nasal swabs, milk) were cultured as previously described \[[@pone.0137143.ref001]\], with slight modifications. Selective enrichment cultures were plated on Oxacillin Resistance Screen Agar (ORSA, Oxoid, Basingstoke, UK). Suspect *S*. *aureus* colonies (denim blue colonies on ORSA) were subcultured in 5% sheep blood agar and incubated at 37°C for 24 h. In some cases, animal isolates from passive surveillance were detected by direct plating on 5% sheep blood agar or on selective agar (ORSA). *S*. *aureus* isolates were identified by means of standard techniques: colony morphology, Gram staining, catalase, coagulase tube test and further confirmed by PCR assay of the *nuc* gene as previously described \[[@pone.0137143.ref014]\].

In order to determine whether the difference between two proportions was significant (presence of genetic or phenotypic characteristics in isolates from swine *vs* isolates from ruminants and humans), the Fisher exact test was calculated by using the StatCalc utility of the Epi Info version 7.1.5 software (<http://wwwn.cdc.gov/Epiinfo/7/index.htm>).

Antimicrobial Susceptibility Testing {#sec003}
------------------------------------

Isolates were tested for their antimicrobial susceptibility by broth micro-dilution (Trek Diagnostic Systems, Westlake, OH, USA). MICs were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST; [http://www.eucast.org](http://www.eucast.org/)), using epidemiological cut-offs. The following drugs were tested: penicillin, cefoxitin, ciprofloxacin, chloramphenicol, clindamycin, erythromycin, gentamicin, kanamycin, streptomycin, linezolid, quinopristin/dalfopristin, fusidic acid, mupirocin, rifampicin, tetracycline, tiamulin, sulfamethoxazole, trimethoprim and vancomycin.

Methicillin Resistance {#sec004}
----------------------

All isolates were tested by PCR for the *mecA gene* \[[@pone.0137143.ref015]\], or by means of a multiplex PCR for *mecA*, *mecC*, *spa* and PVL genes \[[@pone.0137143.ref016]\].

Genotyping {#sec005}
----------

All the isolates were submitted to molecular characterization using *spa*-typing \[[@pone.0137143.ref017]\] and Multilocus Sequence Typing (MLST) \[[@pone.0137143.ref018]\]. The *SCCmec* typing of MRSA isolates was obtained by using gene-specific PCRs. Briefly, all the isolates were tested for the cassette types I-VI, VIII and IX using two multiplex PCRs \[[@pone.0137143.ref019]\]. In case of negative result for the *mec* gene complex, a PCR \[[@pone.0137143.ref020]\] for the *mec* gene C1 (present in the VII and X *SCCmec* types) was performed. Identified SCC*mec* type IV variants were further subtyped as previously described \[[@pone.0137143.ref021]\].

Micro-Array Testing {#sec006}
-------------------

Micro-array testing for the detection of a variety of pathogenicity and virulence-associated genes, antimicrobial resistance genes and strain- or host-specific markers of *S*. *aureus*, including the accessory gene regulators (*agr*) genes and superantigenic-toxin encoding genes was performed by a genotyping kit (Alere GmbH, Germany), as previously described \[[@pone.0137143.ref009]\]. The results were interpreted according to the manufacturer's specifications.

Macrorestriction-PFGE {#sec007}
---------------------

All the CC1 *S*. *aureus* isolates were sub-classified using macrorestriction-PFGE \[[@pone.0137143.ref022], with modifications\]. After 4h incubation with 30U of SmaI (Thermo Fisher Scientific, Waltham, USA) at 30°C, the digested plugs were placed in the agarose gel. The run was performed in a CHEF-DRII (Bio-Rad Laboratories GmbH, Munich, Germany) system according a previously harmonized protocol \[[@pone.0137143.ref023]\]. Cluster analysis was performed using BioNumerics 7 software (Applied Maths, Sint-Martens-Latem, Belgium), and a dendrogram was built applying the Dice Similarity coefficient with an optimization and tolerance of 1.5% each, and clustering using Unweighted Pair Group Method with Arithmetic Mean (UPGMA). *S*. *aureus* NCTC 8325 was the size standard strain used.

Results {#sec008}
=======

Genotyping and Array Typing {#sec009}
---------------------------

All CC1 isolates were ST1, *spa*-type t127, except one ST1 MSSA isolate from an Italian pig holdings (*spa*-type t114). All but two porcine MRSA (Italy, Cyprus, with *SCCmec* IVa) carried *SCCmec* cassette type V (5C2), while all bovine and human MRSA carried SCC*mec* cassette type IVa, except two human isolates which carried *SCCmec*V&*SCCfus*, harbouring *fus*C, gene mediating fusidic acid resistance.

None of isolates from livestock and only 20% (4/20) of the human MSSA/MRSA isolates were PVL-positive (all isolates from Italy). All isolates were positive for genes of other leukotoxin families: LukF-LukS, LukD-LukE, Luk-X-LukY. All isolates carried the haemolysins (or putative membrane proteins) *hl*, *hlb*, *and hlIII* genes and 90% (75/83) also carried the *hla* gene. All MRSA isolates form pigs presented the undisrupted variant of the *hlb* gene, except the isolate from Cyprus.

Nineteen out of twenty human isolates (12 MRSA and 7 MSSA), 10/19 bovine (9 MRSA and one MSSA), the ovine and the porcine isolates from Cyprus harboured IEC genes, *sak* and *scn*, except for two human isolates and two bovine isolates that tested positive for the *sak* gene only. All isolates belonged to the agr type III group. All isolates had a similar pattern of capsule and biofilm-associated genes, with *capH8; capI8; capJ8; capK8; icaA; icaC; icaD* as the most frequent pattern (66 MRSA and 9 MSSA (75/83)). All isolates carried genes encoding "microbial surface components recognizing adhesive matrix molecules" (MSCRAMMs): *bbp*, *clfA*, *clfB*, *cna*, *ebh*, *ebpS*, *eno*, *fib*, *fnbA*, *fnbB*, *map*, *sasG*, *sdrC*, *sdrD*, and all carried hyaluronate lyase genes (*hysA1*, *hysA2)*. Other virulence genes such as protease genes were also present in all isolates (the most frequent pattern was: *aur*; *splA*; *splB*; *splE*; *sspA*; *sspB*; *sspP*, found in 42/83 isolates). All isolates tested positive for the Von Willebrand binding protein gene *vwb* (COL+MW2 probe), and were negative for the SAPI-encoded *vwb* (RF122) allelic variant.

All isolates were positive for several superantigens/enterotoxin-like (*ssl*/*set*) genes, and for the *seh* \[[@pone.0137143.ref024]\]. 12/20 human isolates (5 MRSA and 7 MSSA) and one bovine isolate (MSSA) also carried *sea*, *seb*, *sek*, *seq* in different combinations, with none positive for *tst*1 (either human or bovine alleles) or any of the exfoliative toxin genes (*eta*, *etb* and *etd*).

As regards antimicrobial resistance genes, 73% (52/71) of MRSA isolates carried the *tet*(K) gene, and only three MRSA from swine and one of human origin (MSSA) carried *tet*(M). Just one of these, a swine MRSA, carried both *tet*(K) and *tet*(M) genes, while only 4 swine MRSA were tetracycline susceptible. Gentamicin-kanamycin resistance (MIC \> 4 mg/L; \> 64 mg/L, respectively) mediated by the *aacA-aphD* genes, was a feature of the porcine cluster (9/43, 20.9%), often in co-presence with *aadD*, while all kanamycin-resistant bovine/ovine and human isolates (30/40, 75%) carried *aphA3* and *sat* (conferring streptothricin resistance) only. Conversely, this latter combination of genes was significantly lower and rare in pig isolates (Fisher exact test p\<0.0001), where it was found in 1/11 (9.1%) of kanamycin-resistant isolates. An exception were three human MRSA isolates: among these, the Danish isolate carried the *aacA-aphD* and *aadD* genes, whereas the Italian ones carried both *aacA-aphD* and *aphA3* and *sat* genes ([Fig 1](#pone.0137143.g001){ref-type="fig"}). Additionally, amphenicol resistance (a feature specific of the Italian isolates) was mediated by *cat*, or *fex*A and *cfr*, detected in 14% (6/43) of pig isolates. Macrolide-lincosamide (ML)-resistance was mediated most frequently by *erm*(C) (n = 27), mainly in Italian isolates, or by *erm*(A) (n = 7 isolates, from Italy and Spain), or by both genes (n = 16 isolates from Italy; n = 2 from Spain). No *erm*(A)-mediated ML-resistance was found in human or bovine/ovine isolates. In one pig isolate from Spain, the *lnu* gene, mediating lincosamide resistance was found in combination with *erm*(A).

Pleuromutilin microbiological resistance (tiamulin MIC\>4 mg/L) was detected in 24/43 (56%) pig isolates, and was found to be mediated by *vga*(A) gene in 47% of these isolates (20/43; 18 MRSA and 2 MSSA, [Fig 1](#pone.0137143.g001){ref-type="fig"}), and in one case by the *cfr* methyltransferase gene, also mediating amphenicol, oxazolidinone and streptogramin A resistance ([S1 Table](#pone.0137143.s001){ref-type="supplementary-material"}).

Many isolates (36/83, 43.4%) showed a fluoroquinolone resistance phenotype, with all but one isolates being of swine origin (32/33) and one of bovine origin, with a ciprofloxacin (CIP) MIC range 8 - ≥16 mg/L. The remainder two isolates (bovine and human origin, respectively) had a CIP MIC of 2 mg/L. Again, proportions of both pleuromutilin and fluoroquinolone resistance in isolates of swine origin were significantly higher from those found in isolates of human/ruminant origin (Fisher exact test p\<0.0001). All isolates carried *sdrM*, a chromosomally-encoded multidrug efflux pump, and five porcine and one human isolates the plasmid borne *qac*C, conferring resistance to quaternary ammonium compounds. The complete data set of genes investigated, including the microarray results, and antimicrobial resistance patterns is available in [S1 Table](#pone.0137143.s001){ref-type="supplementary-material"}.

Analysis of PFGE Macro-Restriction Patterns {#sec010}
-------------------------------------------

The dendrogram deduced from the PFGE macrorestriction profiles allowed a separation of 50 different PFGE profiles (A to AX) clustering into three main clusters (I-III) when using an 80% similarity cut-off, and each of them could be partitioned in subclusters (a, b, c,...), based on a 90% similarity ([Fig 1](#pone.0137143.g001){ref-type="fig"}).

Specifically, cluster I is composed of swine isolates only, carrying SCC*mec* V (Italian and Spanish origin), and only one isolate of human origin (Staph 151, MRSA) although this human isolate was the only one presenting characteristics typical of human-associated CC1 (*sak* and *scn* genes within the IEC).

Conversely, cluster III is mainly composed of isolates from humans and from cattle, characterized by SCC*mec* type IV (2B and its variant 2B&5), harbouring other human-associated CC1 genes, such as the IEC genes, and the *sat* and *aph*A3 resistance genes. They lacked the *erm*(A) mediated macrolide-lincosamide resistance. Subcluster IIIe, comprising the majority of human and bovine isolates, includes thirteen PFGE-indistinguishable isolates of human and bovine origin, sometimes also sharing the same pattern of resistance genes ([Fig 1](#pone.0137143.g001){ref-type="fig"}). The single MSSA isolate of ovine origin (Italy) harbouring human-associated marker genes showed a high similarity (Dice coefficient \>90%) with one human MSSA from Italy by PFGE (subcluster III.a). All pig isolates from Finland grouped together in the subcluster III.c. The only MRSA of swine origin clustering with human and bovine isolates (III.e) is a Cypriot isolate (from dust swab) with other genetic features (*SCCmec* IVa; *aphA3*, *sat*; *sak*, *scn*) associated with human isolates.

Discussion {#sec011}
==========

This study represents the first wide molecular characterization of MRSA CC1 isolates from farm animals, and offers a further insight into relatedness and similarities with a set of CA-MRSA isolates from in humans.

Macrorestriction-PFGE clusters showed an impressive concordance with host of isolation and a series of other genetic markers (virulence, antimicrobial resistance) that are often carried by mobile genetic elements (MGEs), bacteriophages, and subject to loss or acquisition in relation to host adaptation process, useful for molecular epidemiology ([Fig 1](#pone.0137143.g001){ref-type="fig"}). Among these, *SCCmec* V is clearly a feature of porcine isolates, almost all in cluster I, while human and bovine MRSA isolates (cluster III) are characterized by *SCCmec* IVa. An exception is a single human MRSA SCC*mec* V (Staph 151), clustering with the porcine isolates, although also showing phage- or transposon- encoded genes typical of human adapted strains ([Fig 1](#pone.0137143.g001){ref-type="fig"}). Interestingly, we also report the finding of *SCCmec*V&*SCCfus* in two human isolates (from Italy and Denmark), an occurrence that has only been scarcely reported so far \[[@pone.0137143.ref025]\].

Striking is that swine MRSA isolates from Finland, show a high degree of similarity (subcluster III.c), and although with a *SCCmec* V, they seem more closely related to the human-bovine cluster (grouped in subcluster III.b) than the porcine isolates from Italy and Spain (cluster I). Conversely, they lacked all other acquired resistance genes, except for *tet*(K) and *blaZ* ([Fig 1](#pone.0137143.g001){ref-type="fig"}), and fluoroquinolone resistance, which is a typical feature of porcine multidrug-resistant MRSA CC1 isolates from Italy and from Spain. This is probably explained by a low antimicrobial usage in Finnish pig industry as shown in the ESVAC Reports \[[@pone.0137143.ref026]\]. Additionally, among the specific genetic markers of the Italian and Spanish multidrug-resistant MRSA of porcine origin is the presence of pleuromutilin resistance, mostly attributed to the *vga*(A) gene and also contributing to combined resistance to streptogramins A and lincosamides \[[@pone.0137143.ref027]\], in agreement to what has been previously reported in porcine MRSA \[[@pone.0137143.ref009]\]. Interestingly, resistance to quaternary ammonium compounds, commonly used in sanitization procedures in pig holdings \[[@pone.0137143.ref028]\] was another feature of Italian porcine isolates (cluster I), and was detected in one Danish human isolate only (cluster III).

Typically, all isolated studied including those from cattle/sheep, lack the SAPI-encoded bovine *vwb* gene, an important trait of host-specific pathogenicity, and this may be considered as one of the indications of a recent transfer of this lineage to food-producing animals, and especially to the ruminant hosts. As for the enterotoxin gene profile, *seh* appears to be constitutive of the ST(CC)1, irrespective of the host of origin, as previously observed \[[@pone.0137143.ref009]\]. Additionally, the pattern *sea*-*seh*-*sek*-*seq* is a feature typical of human isolates, since it has been found in only one IEC-positive MSSA isolate of animal origin, from a dairy cattle herd, clustering with human isolates (cluster II).

Most interestingly, the vast majority of isolates from dairy cattle (and sheep), shared a lot of genetic features usually found in typical human-associated CC1 clones. Amongst these are the immune evasion cluster (IEC) genes *sak* and *scn*, located on β-haemolysin-converting bacteriophages \[[@pone.0137143.ref029]\] and *sea*. Indeed, among the *sak*- or *scn*-positive isolates, ten were also positive for the enterotoxin *sea* gene, of which n = 9 isolated from humans (3 MRSA and 6 MSSA), while only one (MSSA) from dairy cattle. Similarly, almost all isolates from cattle and sheep often carried *sat* and *aph*A3 resistance genes associated with Tn5405-like elements, to be considered as further markers of a human origin \[[@pone.0137143.ref030],[@pone.0137143.ref031]\]. Another characteristic of the human-bovine profile was the absence of *erm*(A) mediated macrolide-lincosamide resistance, and the rare occurrence of fluoroquinolone resistance, which is an epidemiological marker for Italian and Spanish porcine isolates.

All these features may be suggestive of a recent adaptation to the bovine (ruminant) host of human-associated CC1 strains, compared to the porcine cluster. A possible pathway of human-to-cattle exchange may be direct contact between farm workers and animals or indirect exposure through farm environment. Exposure of dairy animals is likely to result in colonization and even infection, since it is known that ST1 MRSA is capable of causing mastitis in cattle and mastitis/colonization in small ruminants \[[@pone.0137143.ref012]\]. A longitudinal study on a single case of chronic mastitis in a dairy cow \[[@pone.0137143.ref010]\], reported shedding over time, with immune response indicating acute infection, and neutrophils as the most represented cell population. Indeed, the first case of ST1 *spa*-type t127 *SCCmec* IVa mastitis in cattle was reported in Hungary in 2002, and showed PFGE-indistinguishable isolates amongst dairy cattle and one of the workers at the farm \[[@pone.0137143.ref032]\]. Unfortunately no further molecular typing was performed on these strains.

In conclusion, all MRSA CC1 isolates studied, irrespective of their host (animal or human) origin possess several virulence genes and resistance genes towards major classes of antimicrobials, and a variety of other pathogenicity factors. In this respect, MRSA in farm animals, either of bovine or swine origin, are to be considered a hazard for the community, and may represent a serious therapeutic challenge in case of invasive infections in humans.

Additionally, the finding that most of ST(CC)1 MRSA and MSSA associated with cattle in Italy, besides being multidrug-resistant and showing very high genetic relatedness ([\>]{.ul}90--100% PFGE similarity) to human isolates, also possess some of the virulence and immunomodulatory (e. g. IEC cluster) marker genes associated with full capability of colonizing and infecting humans, is of further concern. Since this clone has been demonstrated causing mastitis in cattle, with shedding of the pathogen over the lactation cycle, dairy farming may represent a source of exposure for the community also through unpasteurized milk or dairy products. With these genetic characteristics, spill-over from food-producing animals in high-prevalence geographic areas should be taken seriously. Prevention efforts should include actions to be taken at farm-level, aimed at minimizing exposures in the community and in categories directly related to farm animal industry.

Supporting Information {#sec012}
======================

###### Dataset with metadata, genes investigated by microarray or PCR, and antimicrobial susceptibility tests and patterns of n = 83 *S*. *aureus* (MSSA, MRSA) ST(CC1) of animal and human origin.

Legend: ^\#^: Ambiguous result.
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